NEW! NOW AVAILABLE!
Top300Bio CDMO Facility Index and Biomanufacturers Database
BioPlan has developed the only Global Contract Development and Manufacturing Facilities Index and Database that actively tracks over 400+ dedicated CDMO facilities providing development and manufacturing services for biopharmaceuticals.
Clinical and commercial biologics CDMOs accounted for $16.89 billion in sales in 2023, growing at 17% annually. Now you can track and benchmark this growth.
Based on 30 years of evaluating and benchmarking the biopharmaceutical and life sciences industry, this database is updated continually and includes comprehensive information and insights.
Our analysis uses publicly available information and data amassed over decades, and is regularly reviewed by experts to ensure accuracy.
Contact us directly for Demo and Pricing
Click here for more information (PDF]
Click here to view – Top300Bio CDMO Facility Index and Database
WHAT YOU’LL GET:
- Full 1-year Subscription
- Biofacilities Quarterly Newsletter (Free! Save $950)
- Comprehensive annual review
- Dashboard: Searchable and sortable
- Access to live analysts for queries and input
HIGHLIGHTS
RANKING AND INDEXING
Top300Bio CDMO Facility Index ranks each ‘dedicated’ CDMO facility and provides
regional quantitative analysis of biomanufacturing regions and clusters.
- Total bioreactor liter capacity
- CDMO/CMO service expertise
- Future Biomanufacturing capacity coming online
- Number of commercial and clinical biological products manufactured
- Revenue estimates
- Strengths and Challenges
- Technologies and expertise, and much more
APPLICATIONS FOR THE TOP300BIOCDMO.COM
- Identify your ideal CDMO or partners
- Identify specialized expertise such as cell or gene therapy, pDNA, mRNA
- Early-stage companies and new market entrants identify potential manufacturing partners
- Facility siting: Locate qualified employees; reduce hiring challenges
- Sales territory allocations: Determine where and how to staff territories
- Market Competition: Identify CDMO competitors’ strengths and weaknesses
- Real estate valuation: For facilities, based on regional attractiveness
- HR and Recruiters: Looking for a critical mass of educated and skilled staff
- Industry Growth: Find where the industry is growing most rapidly
- Emerging Regions: CDMO Facilities in China, India, Latin America, Middle East regions
- CDMO Company Ranking: How do CDMO facilities rank, in skills, employment, capacity
For more information about subscriptions, please contact:
BioPlan Associates, Inc.
One Research Center, Suite 450
Rockville, MD 20850
+1 301-921-5979
dgillespie@bioplanassociates.com
